Vijaya Diagnostic Centre Limited - Asset Resilience Ratio

Latest as of March 2026: 16.55%

Vijaya Diagnostic Centre Limited (VIJAYA) has an Asset Resilience Ratio of 16.55% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs2.49 Billion

≈ $26.98 Million USD Cash + Short-term Investments

Total Assets

Rs15.07 Billion

≈ $162.98 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2026)

This chart shows how Vijaya Diagnostic Centre Limited's Asset Resilience Ratio has changed over time. Check VIJAYA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Vijaya Diagnostic Centre Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Vijaya Diagnostic Centre Limited market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.49 Billion	16.55%
Total Liquid Assets	Rs2.49 Billion	16.55%

Asset Resilience Insights

Good Liquidity Position: Vijaya Diagnostic Centre Limited maintains a healthy 16.55% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Vijaya Diagnostic Centre Limited Industry Peers by Asset Resilience Ratio

Compare Vijaya Diagnostic Centre Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Genoray Co. Ltd KQ:122310	Diagnostics & Research	2.14%
GeneMatrix Inc KQ:109820	Diagnostics & Research	41.52%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Cryosite Ltd AU:CTE	Diagnostics & Research	5.65%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%

Annual Asset Resilience Ratio for Vijaya Diagnostic Centre Limited (2019–2026)

The table below shows the annual Asset Resilience Ratio data for Vijaya Diagnostic Centre Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	16.55%	Rs2.49 Billion ≈ $26.98 Million	Rs15.07 Billion ≈ $162.98 Million	+2.06pp
2025-03-31	14.49%	Rs1.85 Billion ≈ $19.96 Million	Rs12.74 Billion ≈ $137.74 Million	+3.39pp
2024-03-31	11.10%	Rs1.09 Billion ≈ $11.80 Million	Rs9.83 Billion ≈ $106.28 Million	-15.99pp
2023-03-31	27.10%	Rs2.31 Billion ≈ $25.01 Million	Rs8.53 Billion ≈ $92.29 Million	-2.91pp
2022-03-31	30.01%	Rs2.14 Billion ≈ $23.15 Million	Rs7.13 Billion ≈ $77.16 Million	-9.35pp
2021-03-31	39.36%	Rs2.13 Billion ≈ $23.02 Million	Rs5.41 Billion ≈ $58.50 Million	+15.49pp
2020-03-31	23.86%	Rs1.15 Billion ≈ $12.45 Million	Rs4.82 Billion ≈ $52.15 Million	-3.16pp
2019-03-31	27.03%	Rs1.10 Billion ≈ $11.88 Million	Rs4.06 Billion ≈ $43.95 Million	--

pp = percentage points

About Vijaya Diagnostic Centre Limited

NSE:VIJAYA India Diagnostics & Research

Market Cap

$1.46 Billion

Rs135.11 Billion INR

Market Cap Rank

#7220 Global

#354 in India

Share Price

Rs1313.10

Change (1 day)

-1.37%

52-Week Range

Rs861.40 - Rs1412.50

All Time High

Rs1412.50